Revolutionizing Precision Medicine
This is an article about portfolio company, Genomenon.
An accomplished businessman, a strategic thinker and an excellent leader, Mike Klein has been responsible for raising over $50 million in private equity and venture capital financing over the years. He has drawn on a unique blend of vision, tactical thinking, communication and, execution skills in the last 25 years of his career. Mike’s technical and financial backgrounds have helped him bolster businesses and meet their objectives while driving revenue growth. Excerpts from an interview with Mike Klein, CEO, Genomenon:
View source version on tech-ceos.com: https://www.tech-ceos.com/genomenon/